单中心1000例儿童IBD全外显子测序:单基因变异患病率与临床特征
对加拿大单中心1005例0-18岁IBD患儿进行全外显子测序,发现3%携带罕见单基因变异,其中1%的变异可通过异基因造血干细胞移植纠正。单基因IBD在6岁以下患儿中占7.8%,6-18岁占2.3%,与早发、自身免疫病家族史、肠外表现和手术相关。
要点
- 儿童IBD中单基因变异患病率约3%,6岁以下达7.8%。
- 单基因IBD与发病年龄<2岁、自身免疫病家族史、肠外表现和手术相关。
- 约1%患儿携带可通过异基因造血干细胞移植纠正的基因变异。
核心结论
- 在1005例儿童IBD中,3%携带与儿童IBD相关的罕见单基因变异,1%的变异可通过异基因造血干细胞移植潜在纠正。
- 单基因IBD虽罕见,但所有儿童期起病的IBD患者均应考虑相关分析。
研究设计与样本
- 对加拿大单中心未选择的1005例0-18岁IBD患儿(诊断中位年龄11.96岁)及家庭成员共2305份样本进行全外显子测序。
- IBD相关变异用Sanger测序验证,患者活检组织进行免疫荧光和组织化学分析。
主要发现
- 在31/1005例患儿中鉴定出21个单基因基因的40个罕见变异,包括XIAP变异5个、DOCK8变异3个、FOXP3、GUCY2C和LRBA各2个。
- 单基因变异在<6岁患儿中占7.8%,在6-18岁患儿中占2.3%。
- 17例单基因克罗恩病患者中,35%有腹痛,24%有非血性稀便,18%有呕吐,18%有体重下降,5%有间歇性血性稀便。
- 14例单基因溃疡性结肠炎或IBD未分类患者诊断年龄更小,最主要特征为血性稀便(78%)。
关键数值与推荐
- 单基因变异总体患病率3%(31/1005),<6岁为7.8%,6-18岁为2.3%。
- 17例患者携带的基因变异可通过异基因造血干细胞移植纠正,占1%。
临床怎么用
- 对儿童期起病IBD,尤其发病年龄<2岁、有自身免疫病家族史、肠外表现或需手术者,应考虑单基因IBD的基因检测。
- 识别可经异基因造血干细胞移植纠正的基因变异,可能影响治疗决策。
局限性
- 单中心研究,结论外推需谨慎。
- 样本来自加拿大单中心,人群代表性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: A proportion of infants and young children with inflammatory bowel diseases (IBDs) have subtypes associated with a single gene variant (monogenic IBD). We aimed to determine the prevalence of monogenic disease in a cohort of pediatric patients with IBD. METHODS: We performed whole-exome sequencing analyses of blood samples from an unselected cohort of 1005 children with IBD, aged 0-18 years (median age at diagnosis, 11.96 years) at a single center in Canada and their family members (2305 samples total). Variants believed to cause IBD were validated using Sanger sequencing. Biopsies from patients were analyzed by immunofluorescence and histochemical analyses. RESULTS: We identified 40 rare variants associated with 21 monogenic genes among 31 of the 1005 children with IBD (including 5 variants in XIAP, 3 in DOCK8, and 2 each in FOXP3, GUCY2C, and LRBA). These variants occurred in 7.8% of children younger than 6 years and 2.3% of children aged 6-18 years. Of the 17 patients with monogenic Crohn's disease, 35% had abdominal pain, 24% had nonbloody loose stool, 18% had vomiting, 18% had weight loss, and 5% had intermittent bloody loose stool. The 14 patients with monogenic ulcerative colitis or IBD-unclassified received their diagnosis at a younger age, and their most predominant feature was bloody loose stool (78%). Features associated with monogenic IBD, compared to cases of IBD not associated with a single variant, were age of onset younger than 2 years (odds ratio [OR], 6.30; P = .020), family history of autoimmune disease (OR, 5.12; P = .002), extra-intestinal manifestations (OR, 15.36; P < .0001), and surgery (OR, 3.42; P = .042). Seventeen patients had variants in genes that could be corrected with allogeneic hematopoietic stem cell transplantation. CONCLUSIONS: In whole-exome sequencing analyses of more than 1000 children with IBD at a single center, we found that 3% had rare variants in genes previously associated with pediatric IBD. These were associated with different IBD phenotypes, and 1% of the patients had variants that could be potentially corrected with allogeneic hematopoietic stem cell transplantation. Monogenic IBD is rare, but should be considered in analysis of all patients with pediatric onset of IBD.
引用
- Crowley E, Warner N, Pan J, et al. Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center. Gastroenterology. 2020. PMID: 32084423. doi:10.1053/j.gastro.2020.02.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。